The extreme paucity of clinical trials on sarcopenia in literature is mainly due to difficulties in designing studies able to isolate the aging process from its multiple and interconnected consequences.
emergence of many promising interventions towards this age-related condition (e.
g.
, physical exercise [in particular, resistance training], testosterone, antioxidant supplementations), the need for Phase II trial designs is high.
Clinical trials are needed to find better interventions for this syndrome.
This trial was registered at clinical trials.
gov as NCT00794079.
.
